Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
MapLight Therapeutics, Inc.
Market Cap
$394.45M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$390.22M
Operating Margin
-94.08%
TTM Avg
-187.30%
3Y Avg
-226.23%
5Y Avg
-158.01%
Market Cap
$402.33M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
2.78%
Market Cap
$385.39M
Operating Margin
-3.05%
TTM Avg
-9.46%
3Y Avg
-10.10%
5Y Avg
-7.29%
Market Cap
$403.70M
Operating Margin
-61.09%
TTM Avg
-74.66%
3Y Avg
-94.75%
5Y Avg
-94.75%
Market Cap
$407.02M
Operating Margin
0.00%
TTM Avg
-4465.14%
3Y Avg
-2232.57%
5Y Avg
-1488.38%
Market Cap
$407.12M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$407.71M
Operating Margin
-58.53%
TTM Avg
-50.96%
3Y Avg
-52.76%
5Y Avg
-52.76%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MapLight Therapeutics, Inc. (MPLT) | $394.45M | 0.00% | 0.00% | 0.00% | N/A |
| REGENXBIO Inc. (RGNX)vs › | $390.22M | -94.08% | -187.30% | -226.23% | -158.01% |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $402.33M | 0.00% | 0.00% | 0.00% | 2.78% |
| Orthofix Medical Inc. (OFIX)vs › | $385.39M | -3.05% | -9.46% | -10.10% | -7.29% |
| Carlsmed, Inc. (CARL)vs › | $403.70M | -61.09% | -74.66% | -94.75% | -94.75% |
| Neurogene Inc. (NGNE)vs › | $407.02M | 0.00% | -4465.14% | -2232.57% | -1488.38% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $407.12M | 0.00% | 0.00% | 0.00% | 0.00% |
| Shoulder Innovations, Inc. (SI)vs › | $407.71M | -58.53% | -50.96% | -52.76% | -52.76% |
| Rezolute, Inc. (RZLT)vs › | $409.24M | 0.00% | 0.00% | 0.00% | 0.00% |
| Myriad Genetics, Inc. (MYGN)vs › | $411.79M | -12.22% | -9.37% | -14.04% | -19.79% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-03-31 | 0.00% |
